Trust Point Inc’s Idexx Laboratories IDXX Stock Holding History

Trust Point Inc’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	442 +3	+0.7%	+$1.68K	0.02%	416
2026 Q1	$247K	Buy	439 +112	+34%	+$71.8K	0.02%	446
2025 Q4	$221K	Sell	327 -20	-6%	-$13.6K	0.02%	443
2025 Q3	$222K	Buy	+347	New	+$211K	0.02%	445
2024 Q4	–	Sell	-451	Closed	-$228K	–	571
2024 Q3	$228K	Buy	+451	New	+$219K	0.02%	462
2024 Q2	–	Sell	-453	Closed	-$245K	–	517
2024 Q1	$245K	Buy	+453	New	+$248K	0.02%	457

Other funds holding IDXX

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return

Trust Point Inc's IDXX Position: Q2 2026 in Review

Trust Point Inc increased its Idexx Laboratories (IDXX) stake by 0.68% in Q2 2026, buying an estimated $1.68K and bringing the position to 442 shares worth $233K. The position accounts for 0.02% of the portfolio, ranked #416.

Trust Point Inc first reported a position in IDXX in Q1 2024 and has held it in 6 quarters since. The position peaked at $247K in Q1 2026. 306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Trust Point Inc held 442 shares of Idexx Laboratories worth $233K as of Q2 2026.
Trust Point Inc bought 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
Idexx Laboratories made up 0.02% of Trust Point Inc's portfolio in Q2 2026, its #416 holding.
Trust Point Inc first reported a position in Idexx Laboratories in Q1 2024 and has held it in 6 quarters since.
Trust Point Inc's Idexx Laboratories position peaked at $247K in Q1 2026.
306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.